Inogen | INGN - Costo Del Venduto





Costo Del Venduto Cambiamento Data
Abbott USD 4.92B 535M 2025-12
Accuray USD 116.17M 14.63M 2024-12
AngioDynamics USD 37.29M 786K 2025-09
Artivion USD 42.85M 3.86M 2025-12
AtriCure USD 35.16M 2.23M 2025-12
Baxter International USD 2.4B 512M 2025-12
Becton, Dickinson and Co. USD 2.84B 2.35B 2025-12
Boston Scientific USD 1.84B 82M 2025-12
Chart Industries USD 775M 7.5M 2025-09
Cooper Companies USD 376.8M 87.4M 2025-12
Dexcom USD 466.9M 11M 2025-12
Edwards Lifesciences USD 343M 2.2M 2025-12
Globus Medical USD 290.47M 8.09M 2025-12
Inogen USD 39.59M 1.27M 2024-09
Insulet USD 215.2M 19M 2025-12
Masimo USD 165.2M 24.3M 2025-12
Medtronic USD 3.61B 83M 2025-12
Orthofix International USD 66.63M 6.4M 2025-12
Philips EUR 2.81B 417M 2025-12
ResMed USD 555.85M 29.13M 2025-12
Steris USD 840.7M 26.3M 2025-12
Stryker USD 2.69B 373M 2025-12
Tandem Diabetes Care USD 122.92M 7.96M 2025-12
Teleflex USD 261.54M 199.84M 2025-12
X T L Biopharmaceuticals USD 332K 216K 2024-12
Zimmer Biomet Holdings USD 970.1M 234.3M 2025-12